EXOMIND (BTL-699-2) Active treatment

DEVICE3 trials

Sponsors

BTL Industries Ltd.

Conditions

Depressive SymptomsGeneralized Anxiety Disorder (GAD)Obsessive-Compulsive BehaviorSexual DysfunctionUrinary Incontinence

Unknown Phase

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women

RecruitingNCT07413705

BTL Industries Ltd.Depressive Symptoms, Sexual Dysfunction, Urinary Incontinence

Start: 2025-11-20End: 2026-12-11Target: 60Updated: 2026-02-17

rTMS Device for Improvement of Obsessive and Compulsive Behaviors

Not yet recruitingNCT07679750

BTL Industries Ltd.Obsessive-Compulsive Behavior

Start: 2026-06-24End: 2026-12-01Target: 60Updated: 2026-07-01

Device for Treating Generalized Anxiety

RecruitingNCT07819773

BTL Industries Ltd.Generalized Anxiety Disorder (GAD)

Start: 2026-09-09End: 2027-04-09Target: 40Updated: 2026-09-18